ReviewTherapeutic advances in psychopharmacology2021

MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants.

Tomasz Cholewinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.